BIOMAT Database Logo BIOMAT Database Logo

Potential folic acid antagonists. 6. Potential irreversible folate reductase inhibitors derived from 2,4-diamino-5-arylazopyrimidines. 1971

S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D005493 Folic Acid Antagonists Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) Antifolate,Antifolates,Dihydrofolate Reductase Inhibitor,Folic Acid Antagonist,Dihydrofolate Reductase Inhibitors,Folic Acid Metabolism Inhibitors,Acid Antagonist, Folic,Acid Antagonists, Folic,Antagonist, Folic Acid,Antagonists, Folic Acid,Inhibitor, Dihydrofolate Reductase,Inhibitors, Dihydrofolate Reductase,Reductase Inhibitor, Dihydrofolate,Reductase Inhibitors, Dihydrofolate
D000588 Amines A group of compounds derived from ammonia by substituting organic radicals for the hydrogens. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amine
D001391 Azo Compounds Organic chemicals where aryl or alkyl groups are joined by two nitrogen atoms through a double bond (R-N Azo Dye,Azo Dyes,Compounds, Azo,Dye, Azo,Dyes, Azo

Related Publications

S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne
Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines.
November 1965, Journal of medicinal chemistry,
S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne
2,4-diamino-6-substituted-5-(4-carbethoxyphenylazo) pyrimidines as irreversible inhibitors of folic acid reductase.
April 1966, Journal of pharmaceutical sciences,
S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne
Irreversible enzyme inhibitors. CXVI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-substituted 2,4-diamino-5-phenylpyrimidines. 3.
May 1968, Journal of medicinal chemistry,
S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne
Irreversible enzyme inhibitors. CXX. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-substituted 2,4-diamino-5-phenylpyrimidines with tissue specificity.
May 1968, Journal of medicinal chemistry,
S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne
New compounds: potential antineoplastics. VI. 2,4-Diamino-6-hydroxy-5-arylazopyrimidines and 1,3-dimethyl-5-arylhydrazonoalloxans.
November 1970, Journal of pharmaceutical sciences,
S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne
Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
January 1969, Journal of medicinal chemistry,
S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne
Irreversible enzyme inhibitors. 138. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenethyl)-- 2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine with a terminal sulfonyl fluoride.
January 1969, Journal of medicinal chemistry,
S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne
Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
January 1969, Journal of medicinal chemistry,
S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne
Irreversible enzyme inhibitors. CLXVI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 2,4-diamino-5(3,4-dichlorophenyl)pyrimidine with 6 substituents and some factors in their cell wall transport.
January 1970, Journal of medicinal chemistry,
S S Chatterjee, and J F Moran, and D J Triggle, and A Wayne
Folate antagonists. 22. Antimalarial and antibacterial effects of 2,4-diamino-6-quinazolinesulfonamides.
December 1984, Journal of medicinal chemistry,
Copied contents to your clipboard!